Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oralair in Grass Pollen Rhinoconjunctivitis (VO53.06)
NCT00418379Phase 3Completed
- Sponsor
- Stallergenes Greer
- Start
- Dec 2006
- Primary completion
- Aug 2010
- Countries
- 1
01
Overview
A Phase 3 trial of Oralair in allergic rhinoconjunctivitis (ARC), sponsored by Stallergenes Greer. Started Dec 2006; status: completed.
02
Drugs
Oralair
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00418379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418379.